Similar Papers

Paper Title
Journal
Date
Author
739 A phase 1b/2, open-label, safety, tolerability and efficacy study of NC410 plus pembrolizumab for participants with immune checkpoint inhibitor (ICI) refractory, or MSS/MSI-low ICI naïve advanced or metastatic solid tumors
Han Myint ... Stephanie Zeidan
Journal for ImmunoTherapy of Cancer | VOL. 10
Han Myint, et. al.Han Myint ... Stephanie Zeidan
01 Nov 2022
Abstract B044: Results of a phase 1 dose escalation clinical trial of NXP800, a novel GCN2 activator, in patients with advanced or metastatic solid tumors
Udai Banerji ... Ruth Ruddle
Molecular Cancer Therapeutics | VOL. 22
Udai Banerji, et. al.Udai Banerji ... Ruth Ruddle
01 Dec 2023
Abstract 1368: Population pharmacokinetic-pharmacodynamic analysis of KHK2455 in patients with locally advanced or metastatic solid tumors
Krina Mehta ... Matthew Hruska
Cancer Research | VOL. 81
Krina Mehta, et. al.Krina Mehta ... Matthew Hruska
01 Jul 2021
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
Elizabeth J Davis ... Jason Clark
Journal for ImmunoTherapy of Cancer | VOL. 10
Elizabeth J Davis, et. al.Elizabeth J Davis ... Jason Clark
01 Oct 2022
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
Cost-effectiveness of an additional hysterectomy after initially conservative treatment for cervical adenocarcinoma in situ.
M Schaafsma ... N.E Van Trommel
Gynecologic oncology | VOL. 193
M Schaafsma, et. al.M Schaafsma ... N.E Van Trommel
17 Jan 2025
Primary prevention of post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole: A single-dose prophylactic actinomycin D, associated with uterine evacuation - a long retrospective cohort study.
Elza Maria Hartmann Uberti ... Josenel Maria Barcelos Marçal
Gynecologic oncology | VOL. 193
Elza Maria Hartmann Uberti, et. al.Elza Maria Hartmann Uberti ... Josenel Maria Barcelos Marçal
11 Jan 2025
PD-L1-Expression in in primary and recurrent vulvar squamous cell cancer.
Frederik A Stuebs ... Carol I Geppert
Gynecologic oncology | VOL. 193
Frederik A Stuebs, et. al.Frederik A Stuebs ... Carol I Geppert
10 Jan 2025
Cervical stromal invasion and molecular characterization in stage II-IV endometrial cancers.
Luigi A De Vitis ... Gretchen E Glaser
Gynecologic oncology | VOL. 193
Luigi A De Vitis, et. al.Luigi A De Vitis ... Gretchen E Glaser
10 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.